Thromb Haemost 1997; 77(01): 221-222
DOI: 10.1055/s-0038-1655939
Letter to the Editor
Schattauer GmbH Stuttgart

Anticardiolipin Antibodies and Recurrent Thromboembolism

Arnaud Rance
Service de Médecine vasculaire et Center Claude Berand de recherche sur les maladies vascularies, CHU Broussais, 96 rue Didot, 75674 Paris cedex 14, France
,
Jospeh Emmerich
Service de Médecine vasculaire et Center Claude Berand de recherche sur les maladies vascularies, CHU Broussais, 96 rue Didot, 75674 Paris cedex 14, France
,
Jean-Noël Fiessinger
Service de Médecine vasculaire et Center Claude Berand de recherche sur les maladies vascularies, CHU Broussais, 96 rue Didot, 75674 Paris cedex 14, France
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 19. Juli 1996

Accepted after revision 16. September 1996

Publikationsdatum:
11. Juli 2018 (online)

 
  • References

  • 1 Prandoni P, Simioni P, Girolami A. Antiphospholipid antibodies, recurrent thromboembolism, and intensity of warfarin anticoagulation. Thromb Haemost 1996; 75: 859
  • 2 Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993-997
  • 3 Reber G, Arvieux J, Comby E, Degenne D, De MoerlooseP, Sanmarco M, Potron G. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995; 73: 444-452